Abstract
Background With the advent of large language models (LLM), such as ChatGPT, natural language processing (NLP) is revolutionizing healthcare. We systematically reviewed NLP’s role in rheumatology and assessed its impact on diagnostics, disease monitoring, and treatment strategies.
Methods Following PRISMA guidelines, we conducted a systematic search to identify original research articles exploring NLP applications in rheumatology. This search was performed in PubMed, Embase, Web of Science, and Scopus until January 2024.
Results Our search produced 17 studies that showcased diverse applications of NLP in rheumatology, addressing disease diagnosis, data handling, and monitoring.
Notably, GPT-4 demonstrated strong performance in diagnosing and managing rheumatic diseases. Performance metrics indicated high accuracy and reliability in various tasks. However, challenges like data dependency and limited generalizability were noted.
Conclusion NLP, and especially LLM, show promise in advancing rheumatology practice, enhancing diagnostic precision, data handling, and patient care. Future research should address current limitations, focusing on data integrity and model generalizability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at:
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
